Global CAR-T Cellular Immunotherapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global CAR-T Cellular Immunotherapy Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
A type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient’s blood. Then the gene for a special receptor that binds to a certain protein on the patient’s cancer cells is added to the T cells in the laboratory. The special receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR T cells are grown in the laboratory and given to the patient by infusion. CAR T-cell therapy is used to treat certain blood cancers, and it is being studied in the treatment of other types of cancer. Also called chimeric antigen receptor T-cell therapy.
CAR-T Cellular Immunotherapy report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global CAR-T Cellular Immunotherapy market is projected to reach US$ 913.9 million in 2029, increasing from US$ 632 million in 2022, with the CAGR of 5.0% during the period of 2024 to 2029. Demand from Hospital and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for CAR-T Cellular Immunotherapy industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, CAR-T Cellular Immunotherapy key companies include Fosun Kite Biotechnology, Gilead Sciences, Novartis and Bristol-Myers Squibb, etc. Fosun Kite Biotechnology, Gilead Sciences, Novartis are top 3 players and held % share in total in 2022.
CAR-T Cellular Immunotherapy can be divided into Allogeneic and Autologous, etc. Allogeneic is the mainstream product in the market, accounting for % share globally in 2022.
CAR-T Cellular Immunotherapy is widely used in various fields, such as Hospital, Pharmacy and Other,, etc. Hospital provides greatest supports to the CAR-T Cellular Immunotherapy industry development. In 2022, global % share of CAR-T Cellular Immunotherapy went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CAR-T Cellular Immunotherapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Fosun Kite Biotechnology
Gilead Sciences
Novartis
Bristol-Myers Squibb
Segment by Type
Allogeneic
Autologous
Hospital
Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the CAR-T Cellular Immunotherapy market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, CAR-T Cellular Immunotherapy introduction, etc. CAR-T Cellular Immunotherapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of CAR-T Cellular Immunotherapy market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
CAR-T Cellular Immunotherapy report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global CAR-T Cellular Immunotherapy market is projected to reach US$ 913.9 million in 2029, increasing from US$ 632 million in 2022, with the CAGR of 5.0% during the period of 2024 to 2029. Demand from Hospital and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for CAR-T Cellular Immunotherapy industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, CAR-T Cellular Immunotherapy key companies include Fosun Kite Biotechnology, Gilead Sciences, Novartis and Bristol-Myers Squibb, etc. Fosun Kite Biotechnology, Gilead Sciences, Novartis are top 3 players and held % share in total in 2022.
CAR-T Cellular Immunotherapy can be divided into Allogeneic and Autologous, etc. Allogeneic is the mainstream product in the market, accounting for % share globally in 2022.
CAR-T Cellular Immunotherapy is widely used in various fields, such as Hospital, Pharmacy and Other,, etc. Hospital provides greatest supports to the CAR-T Cellular Immunotherapy industry development. In 2022, global % share of CAR-T Cellular Immunotherapy went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CAR-T Cellular Immunotherapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Fosun Kite Biotechnology
Gilead Sciences
Novartis
Bristol-Myers Squibb
Segment by Type
Allogeneic
Autologous
Segment by Application
Hospital
Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the CAR-T Cellular Immunotherapy market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, CAR-T Cellular Immunotherapy introduction, etc. CAR-T Cellular Immunotherapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of CAR-T Cellular Immunotherapy market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices